Leadership

David A. Dodd

Chairman, President & CEO

Arban Domi, PhD

Director, Vector Development

Mary J. Hauser, PhD

Director, Preclinical Research

Susan Hensley, MS, RAC

VP, Regulatory Affairs

Kelly T. McKee, Jr., MD, MPH

Chief Medical Officer

Mark J. Newman, PhD

Chief Scientific Officer

John Niles

VP, Commercial Development

Thomas O’Brien

VP, Quality Systems and Compliance

Sreenivasa R. Oruganti, PhD

Senior Scientist

J. Marc Pipas, MD

Executive Medical Director, Oncology

Erica Raiden

Director, Clinical Operations

Senthil Ranganathan, PhD

VP, Technical Dev. and CMC OPS

Mark W. Reynolds

Chief Financial Officer

John W. Sharkey, PhD

VP, Business Development

Kathleen A. Walker, PhD

Senior Clinical Director, Vaccines

Jeff Welch

Head, Process Development and MFG

Ashley Zuniga, PhD, PMP

Director, Project Management

12931381317262732363339223252834